Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Irwin Naturals Inc (OP: IWINF )

0.5000 UNCHANGED
Last Price Updated: 9:33 AM EDT, Aug 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Irwin Naturals Inc

< Previous 1 2 3 Next >
Irwin Naturals Sued By East West Bank Over $40M Loan Default
Irwin Naturals faces a $40M loan lawsuit from East West Bank, leading to Chapter 11 bankruptcy. Explore the implications for the supplements company and its investors. 
Via Benzinga
Topics Bankruptcy Lawsuit
Exposures Financial Legal
Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
Defense Dept. Funds Ketamine Study For PTSD Treatment  
Via Benzinga
Irwin Naturals' Bold Leap: Cannabis, Psychedelics Drive Q3 Buzz Despite Falling Revenue & Surging Losses
Irwin Naturals Inc. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety 
Via Benzinga
Irwin Naturals Launches Trio Of Cannabis Tinctures In California
Irwin Naturals Inc. 
Via Benzinga
Irwin Naturals Revenue Sluggish In Q2, Net Loss Grows YOY
Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) reported its financial results for the second quarter of fiscal 2023, the period ended June 30, revealing a slight year-over-year improvement in... 
Via Benzinga
Cannabis Stock Gainers And Losers From August 25, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Irwin Naturals Q1 FY23 Revenue Stagnates YoY, What About Adjusted EBITDA?
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA: 97X) released its financial results for the first quarter and year ended March 31, 2023, revealing revenue of $22.5 million, down 0.4% from $22.6... 
Via Benzinga
Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Psyched: LSD Microdosing For Depression, DMT For Anxiety, MDMA Octopuses And More
Microdosing LSD For Major Depression Treatment Seeks Further Clinical Validation Via New Study Australian psychedelics company MindBio Therapeutics Corp. was granted approval by both the Ethics... 
Via Benzinga
Marijuana Stock Movers For August 15, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Irwin Naturals FY22 Revenue Declines 10.8%, What About Adjusted EBITDA?
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA:97X) revenue in 2022 was $89.5 million, down 10.8% from $100.3 million in 2021. 
Via Benzinga
Cannabis Stock Movers For August 10, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More
EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, Filing A Gap In Regulations 
Via Benzinga
Cannabis Scandal And Resignation Of Oregon Official, USCC's New Leadership & More Executive Moves
New Team Of Top Executives And Experts To Lead USCC Amid Possible Cannabis Policy Reform 
Via Benzinga
Cannabis Stock Movers For July 27, 2023
Via Benzinga
Psychedelics Company Confirms Shares Spinout, Another Fails To File Financials & Gets CTO Issue
Blackhawk and MindBio Complete Plan Of Arrangement, Shares Spinout 
Via Benzinga
Cantor Fitzgerald Discontinues Research Coverage Of The Cannabis Sector
Cantor Fitzgerald has transferred coverage of WM Technology (NASDAQ: MAPS) to Brett Knoblauch. 
Via Benzinga
Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More
Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses 
Via Benzinga
Irwin Naturals Cannabis Products Launch Nationwide In Canada
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA:97X) announced the release of Irwin Naturals Cannabis’ new CBD 25mg Softgels in Canada, available nationwide through the Starseed Medicinal Medical... 
Via Benzinga
Irwin Naturals Acquires Ketamine Media
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA: 97X) acquired Keta Media, LLC, dba Ketamine Media. 
Via Benzinga
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered 
Via Benzinga
Major Ketamine Clinics Chain Decides Not To Pursue Acquisition Deal
Irwin Naturals Inc. 
Via Benzinga
In-Clinic Ketamine Businesses Are Shutting Down All Across The US, A Rising Trend?
Closely following the announcement of what's to become of the new regulations for telehealth, including ketamine therapy, several of in-clinic treatment centers have announced they are closing their... 
Via Benzinga
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets
After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.   
Via Benzinga
Braxia Scientific's Q3 2023 Finances, Update On Upcoming Acquisition With Irwin Naturals
Research and telemedicine company Braxia Scientific Corp. (OTC: BRAXF) has filed its financial statements for the third quarter ended Dec. 
Via Benzinga
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
Two Bills Approved By Hawaii Senators With Governor's Endorsement Hawaii Senate Ways and Means Committee approved a pair of bills aiming to promote and investigate the therapeutic potential of MDMA and... 
Via Benzinga
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
Psychedelics States Reform: Utah, Iowa, Missouri and Oklahoma’s New Bills; Hawaii, Arizona and Washington's Green Lights, New Hampshire's Setback Earlier this week, three bills were introduced and... 
Via Benzinga
Irwin Naturals Acquires Ketamine Clinic In Kentucky Adding $3M In Projected EBITDA
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA:97X) has successfully completed the acquisition of Serenity Health, LLC, a ketamine clinic in Louisville, KY. The agreement with Serenity was... 
Via Benzinga
Psyched: Australia Legalizes Psychedelics Therapy, BC's Decrim, State Bills, Millions For Trials & Clinics
Australian Health Authority To Allow Psilocybin And MDMA-Assisted Therapy For Depression, PTSD Beginning on July 1, 2023, medicines containing psilocybin and MDMA can be prescribed by specifically... 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.